EUVIMEDEUVIMED entdecken
Crossref

Systolic Blood Pressure Targets in Patients With Hypertension With and Without Cardiovascular Disease: A Pooled Analysis of 4 Randomized Clinical Trials

Yizhen Lyu iD, Jiaheng Zhang iD, Yamei Liu iD, Yezhou Liu iD, Wenming Bian, Kangyu Chen iD, Zhixin Jiang iD, Tao Chen iD, Chao Li iD

Circulation: Population Health and Outcomes · 2026

DOI: 10.1161/circoutcomes.125.012643 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Circulation: Population Health and Outcomes, 2026. Verfasst von Yizhen Lyu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology and Health Statistics, School of Public Health, Xi'an Jiaotong University Health Science Center, Xi'an, Shaanxi, China (Yi…. Hauptthemen laut MEDLINE: Hypertension, Blood Pressure, Antihypertensive Agents, Cardiovascular Diseases. Die Arbeit nennt 40 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Inconsistent selection of reference groups may contribute to inconclusive blood pressure control targets for patients with hypertension. This study aims to identify optimal systolic blood pressure (SBP) targets for individuals with and without cardiovascular disease (CVD) by employing a novel metric combining blood pressure magnitude and duration. METHODS: We conducted a secondary analysis of individual-level data from 4 clinical trials (ACCORD, ALLHAT, SHEP, and SPRINT). Participants aged >80 years, with prevalent heart failure, or with missing follow-up SBP measurements or CVD history were excluded. The proportion of time-in-target range (TTR) was estimated using linear interpolation to quantify longitudinal SBP changes across predefined SBP ranges. Associations between TTR and major adverse cardiovascular events were assessed using stratified Cox proportional hazards models, analyzed separately by CVD history, and stratified by study trials, with hazard ratios (HRs) estimated per 10% increase in TTR. Lower TTR within the same target served as the implicit reference. RESULTS: Among 59 727 participants included in the analysis, the mean age was 65.8 (SD, 6.9) years, 52.3% were men, and 24 524 (41.1%) had a history of CVD. Higher TTR within SBP ranges of 110 to 140 mm Hg was consistently associated with a lower risk of major adverse cardiovascular events in participants with and without CVD. For SBP of 110 to 120 mm Hg, HRs were 0.89 (95% CI, 0.86–0.92) in participants without CVD and 0.93 (95% CI, 0.90–0.95) among those with CVD; corresponding HRs were 0.86 (95% CI, 0.83–0.88) and 0.90 (95% CI, 0.88–0.92) for 120 to 130 mm Hg, and 0.94 (95% CI, 0.92–0.96) and 0.93 (95% CI, 0.91–0.95) for 130 to 140 mm Hg. SBP ≥150 mm Hg was associated with increased major adverse cardiovascular event risk in both groups, whereas SBP

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HypertensionBlood PressureAntihypertensive AgentsCardiovascular DiseasesHumansMaleFemaleAgedRandomized Controlled Trials as TopicProportional Hazards ModelsMiddle AgedRisk Factors

Stichwörter der Autor:innen

blood pressurecardiovascular diseasescardiovascular risk factorshypertension

Substanzen

Antihypertensive Agents

Autor:innen und Institutionen

  • Department of Epidemiology and Health Statistics, School of Public Health, Xi'an Jiaotong University Health Science Center, Xi'an, Shaanxi, China (Yizhen Lyu, J.Z., Yamei Liu, Yezhou Liu, W.B., T.C., C.L.).
  • Division of Life Sciences and Medicine, Department of Cardiology, The First Affiliated Hospital of University of Science and Technology of China (USTC), USTC, Hefei, Anhui, China (K.C.).
  • Department of Cardiology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, China (Z.J.).
  • Department of Clinical Sciences, Liverpool School of Tropical Medicine, United Kingdom (T.C.).
  • Key Laboratory of Environment and Genes Related to Diseases (Xi'an Jiaotong University), Ministry of Education, Xi'an, Shaanxi, China (T.C., C.L.).

ORCID-Profile: Yizhen Lyu, Jiaheng Zhang, Yamei Liu, Yezhou Liu, Kangyu Chen, Zhixin Jiang, Tao Chen, Chao Li

Zitieren

APA

Lyu, Y., Zhang, J., Liu, Y., Liu, Y., Bian, W., Chen, K., Jiang, Z., Chen, T., & Li, C. (2026). Systolic Blood Pressure Targets in Patients With Hypertension With and Without Cardiovascular Disease: A Pooled Analysis of 4 Randomized Clinical Trials. Circulation: Population Health and Outcomes. https://doi.org/10.1161/circoutcomes.125.012643

Vancouver

Lyu Y, Zhang J, Liu Y, Liu Y, Bian W, Chen K, et al. Systolic Blood Pressure Targets in Patients With Hypertension With and Without Cardiovascular Disease: A Pooled Analysis of 4 Randomized Clinical Trials. Circulation: Population Health and Outcomes. 2026. doi:10.1161/circoutcomes.125.012643

BibTeX
@article{Lyu2026,
  author = {Lyu, Yizhen and Zhang, Jiaheng and Liu, Yamei and Liu, Yezhou and Bian, Wenming and Chen, Kangyu and Jiang, Zhixin and Chen, Tao and Li, Chao},
  title = {Systolic Blood Pressure Targets in Patients With Hypertension With and Without Cardiovascular Disease: A Pooled Analysis of 4 Randomized Clinical Trials},
  journal = {Circulation: Population Health and Outcomes},
  year = {2026},
  doi = {10.1161/circoutcomes.125.012643}
}
Kostenlos starten →